Page last updated: 2024-08-21

vancomycin and Weight Gain

vancomycin has been researched along with Weight Gain in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Cloud, JW; Espinoza, D; Kelly, CP; Kokkotou, E; Michos, A; Moss, AC; Mustafa, N; O'Brien, M; Pothoulakis, C1
Knibbe, CAJ; Krekels, EHJ; Sherwin, CMT; Smit, C; Zhang, T1
Clarke, SF; Cotter, PD; Murphy, EF; O'Sullivan, O; O'Toole, PW; Ross, RP; Shanahan, F1
Burmistrova, DS; D'yakonova, IN; Ishanova, YS; Kamkina, OV; Rakhmanova, IV1
Angelakis, E; Casalta, JP; Habib, G; Raoult, D; Richet, H; Thuny, F1
Clarke, SF; Cotter, PD; Daly, C; Fouhy, F; Hogan, A; Joyce, A; Marques, TM; Murphy, EF; O'Doherty, RM; O'Sullivan, O; O'Toole, PW; Quigley, EM; Ross, PR; Shanahan, F; Stanton, C1
Bowlin, TL; Butler, MM; Citron, DM; Dvoskin, S; Feng, H; Kelly, CP; Shinabarger, DL; Tzipori, S; Wright, GE1
Hashimoto, Y; Inui, KI; Kokuryo, T; Nakamura, T1

Other Studies

8 other study(ies) available for vancomycin and Weight Gain

ArticleYear
Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Animals; Anti-Infective Agents; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Mesocricetus; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Weight Gain

2008
Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents.
    Clinical pharmacokinetics, 2023, Volume: 62, Issue:5

    Topics: Adolescent; Adult; Female; Humans; Male; Models, Biological; Overweight; Pediatric Obesity; Vancomycin; Weight Gain

2023
Targeting the microbiota to address diet-induced obesity: a time dependent challenge.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Animals; Biodiversity; Colony Count, Microbial; Diet; Gastrointestinal Tract; Male; Mice; Mice, Inbred C57BL; Microbiota; Obesity; Phylogeny; Principal Component Analysis; Time Factors; Vancomycin; Weight Gain

2013
Effect of Successive Administration of Vancomycin and Amikacin on Auditory Function of Immature Animals.
    Bulletin of experimental biology and medicine, 2017, Volume: 162, Issue:4

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Evoked Potentials, Auditory, Brain Stem; Hair Cells, Auditory, Outer; Otoacoustic Emissions, Spontaneous; Rabbits; Time Factors; Vancomycin; Weight Gain

2017
Vancomycin treatment of infective endocarditis is linked with recently acquired obesity.
    PloS one, 2010, Feb-10, Volume: 5, Issue:2

    Topics: Age Factors; Aged; Anti-Bacterial Agents; Body Mass Index; Drug Therapy, Combination; Endocarditis; Female; Gentamicins; Humans; Life Style; Male; Middle Aged; Obesity; Retrospective Studies; Sex Factors; Surveys and Questionnaires; Vancomycin; Weight Gain

2010
Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
    Gut, 2013, Volume: 62, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacteriocins; Blood Glucose; Diet, High-Fat; Drug Delivery Systems; Gene Expression; Inflammation; Intestinal Mucosa; Intestines; Lactobacillus; Male; Metagenome; Mice; Mice, Inbred C57BL; Obesity; Probiotics; Triglycerides; Tumor Necrosis Factor-alpha; Vancomycin; Weight Gain

2013
MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Cricetinae; DNA Gyrase; DNA Topoisomerases, Type I; DNA-Directed DNA Polymerase; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Metronidazole; Mice; Nucleic Acid Synthesis Inhibitors; Species Specificity; Survival Rate; Topoisomerase II Inhibitors; Vancomycin; Weight Gain

2012
Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
    The Journal of pharmacy and pharmacology, 1999, Volume: 51, Issue:2

    Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cilastatin; Cilastatin, Imipenem Drug Combination; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Drug Combinations; Fosfomycin; Glomerular Filtration Rate; Imipenem; Kidney; Male; Nitrogen; Rats; Rats, Wistar; Vancomycin; Weight Gain

1999